Data curation process fully automated
CENTOGENE implements ACTICO’s platform to dramatically accelerate and improve the quality of diagnostic data curation workflow.
CENTOGENE implements ACTICO’s platform to dramatically accelerate and improve the quality of diagnostic data curation workflow.
CENTOGENE engages in diagnosis and research around rare diseases transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. Our goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our extensive rare disease knowledge, including epidemiological and clinical data, as well as innovative
biomarkers. CENTOGENE has developed a global proprietary rare disease platform based on our realworld data repository with over 3.6 billion weighted data points from approximately 570,000 patients representing over 120 different countries as of August 31, 2020.
For patients who are suffering from an undiagnosed rare genetic disease, receiving a diagnosis as early as possible is vital. As a world leader in genetic diagnostics for rare diseases, Rostock-founded CENTOGENE GmbH is committed to accelerating the diagnosis of these conditions. The company’s partnership with Business Rules specialists S&D, and the implementation of the ACTICO decision management platform, has enabled them to succeed in this aim. How? By automating and optimizing the labor intensive diagnostic data curation process.
„The automation we have implemented ultimately helps us deliver better, faster diagnoses. This is possible because the curation process that used to take a month now takes five minutes. It’s dramatic proof of how the ACTICO platform gives us the confidence to apply a similar approach to other processes in the future. Everyone trusts it.”
Prof. Dr. Carsten Ullrich
Director of Artificial Intelligence, CENTOGENE
This case study provides dramatic proof of how the ACTICO platform can deliver significant business value by using a rules-based decision-making engine to automate data curation. In this instance, the business value is enhanced by the benefit to patients of faster, more accurate and continuously updated rare disease diagnosis. Looking to the future, CENTOGENE is keen to replicate their success by applying the same approach to automate other essential processes. Moreover, CENTOGENE is actively exploring how to extend their use of the ACTICO platform to include, for example, the Machine Learning module.